In a stride for epilepsy treatment, GCT (Global Clinical Trials) has been granted regulatory approval to commence a pioneering clinical trial across seven sites in Ukraine. This approval is a key milestone in advancing research and innovative therapies for Ukrainian children by involving them in the study. With Ukraine coming back as a key player in global clinical research, the selection of the country underscores the nation’s reputation as a hub for medical innovation and excellence.
This project represents a beacon of hope, aspiring to achieve not just advancements in epilepsy treatment but also a demonstration of the power of international collaboration in clinical research. With this groundbreaking endeavor, GCT is not only contributing to the future of medicine but also reinforcing Ukraine’s role in the global endeavor to cure neurological diseases.